Intellia Therapeutics, Inc. (NTLA) CEO John Leonard on Q2 2022 Results - Earnings Call Transcript

Aug. 04, 2022 12:57 PM ETIntellia Therapeutics, Inc. (NTLA)
SA Transcripts profile picture
SA Transcripts

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q2 2022 Results Earnings Conference Call August 4, 2022 8:00 AM ET

Company Participants

Ian Karp - Senior Vice President , Investor Relations and Corporate Communications

John Leonard - President and Chief Executive Officer

David Lebwohl - Executive Vice President and Chief Medical Officer

Laura Sepp-Lorenzino - Executive Vice President and Chief Scientific Officer

Glenn Goddard - Executive Vice President and Chief Financial Officer

Conference Call Participants

Joon Lee - Truist Securities

Maury Raycroft - Jefferies

Dae Gon Ha - Stifel

Gena Wang - Barclays

Joseph Thome - Cowen and Company

Swapnil Malekar - Piper Sandler

Salveen Richter - Goldman Sachs

Luca Issi - RBC Capital Markets

Richard Law - Credit Suisse

Greg Harrison - Bank of America

Mani Foroohar - SVB Leerink

Jay Olson - Oppenheimer & Co.

Ry Forseth - Guggenheim Partners

Kostas Biliouris - BMO Capital Markets

Yanan Zhu - Wells Fargo


Good morning. And welcome to the Intellia Therapeutics' Second Quarter 2022 Financial Results Conference Call. My name is Andrew and I will be your conference operator today. Following formal remarks, we will open the call up for a question-and-answer session. This conference is being recorded at the company's request and will be available on the company's website following the end of the call. As a reminder, all participants are currently in listen-only mode. [Operator Instructions].

I will now turn the conference over to Ian Karp, Senior Vice President of Investor Relations and Corporate Communications at Intellia.

Ian Karp

Thank you, operator. And good morning, everyone. Welcome to Intellia Therapeutics second quarter 2022 earnings call. Earlier this morning, Intellia issued a press release outlining the company's progress this quarter as well as topics for discussion on today's call. This release can be found on the Investors and Media section of Intellia's website at This call is being broadcast

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.